1105: mRNA Vaccine For Pancreatic Cancer Continues To Show Promise
Researchers at Memorial Sloan Kettering are developing an mRNA vaccine for pancreatic cancer. A trial indicated a strong immune response in half of the 16 patients, and cancer had not relapsed in six patients after three years.